There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61P25/00
Appearance
Subcategories
This category has the following 10 subcategories, out of 10 total.
C
E
F
G
H
L
M
R
Pages in category "A61P25/00"
The following 22 pages are in this category, out of 22 total.
1
- 18282749. COMPOSITIONS AND METHODS FOR TARGETING INFLAMMATORY OR ACTIVATED CELLS AND TREATING OR AMELIORATING INFLAMMATORY CONDITIONS AND PAIN simplified abstract (The Regents of the University of California)
- 18522503. METHOD FOR PREVENTING AND/OR TREATING AGING-ASSOCIATED COGNITIVE IMPAIRMENT AND NEUROINFLAMMATION simplified abstract (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY)
- 18554762. TETRACYCLIC COMPOUNDS FOR TREATING BRAIN DISORDERS simplified abstract (The Regents of the University of California)
- 18694720. PROMOTING MYELINATION BY N-ACETYLGLUCOSAMINE AND MODULATION OF N-GLYCAN BRANCHING (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18705652. REGENERATIVE GROWTH FACTORS FOR NERVE REPAIR, PREPARATION PROCESSES OF THE SAME, AND TREATMENT METHODS USING THE SAME (The Johns Hopkins University)
- 18708322. OLFACTORY EXTRACELLULAR VESICLES AND USES THEREOF (CORNELL UNIVERSITY)
- 18730028. METHOD OF INHIBITING DEGRADING PROTEASE ACTIVITY IN AGING (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18732998. BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE simplified abstract (Hoffmann-La Roche Inc.)
- 18737782. Anti-Trkb Monoclonal Antibodies And Methods Of Use simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18817153. Methods of Treatment With an Iboga Alkaloid (The Board of Trustees of the Leland Stanford Junior University)
- 18818513. Compositions of Iboga Alkaloids and Methods of Treatment (The Board of Trustees of the Leland Stanford Junior University)
- 18985661. OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS (GENENTECH, INC.)
2
- 20240050440. THERAPEUTIC TARGETS AND AGENTS FOR THE TREATMENT OF TRIOSEPHOSPHATE ISOMERASE (TPI) DEFICIENCY simplified abstract (University of Pittsburgh- Of The Commonwealth System of Higher Education)
- 20240050442. TRIMEPRAZINE DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING A NEUROPSYCHIATRIC DISORDER simplified abstract (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)
B
- Biotechnology patent applications on 12th Jul 2024
- Biotechnology patent applications on April 25th, 2024
- Biotechnology patent applications on July 11th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on March 14th, 2024
- Blockchain patent applications on March 28th, 2024